TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Unimedic Pharma Holding AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 3,777 | 3,628 | 2,967 |
Financial expenses | 1,606 | 1,303 | 1,485 |
Earnings before taxes | -2,964 | -1,780 | -1,625 |
EBITDA | -1,469 | -511 | -169 |
Total assets | 76,849 | 74,290 | 79,181 |
Current assets | 2,955 | 1,134 | 1,183 |
Current liabilities | 7,181 | 12,153 | 6,783 |
Equity capital | 301 | 487 | 903 |
- share capital | 284 | 293 | 314 |
Employees (average) | 0 | 0 | 3 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 0.4% | 0.7% | 1.1% |
Turnover per employee | 989 | ||
Profit as a percentage of turnover | -78.5% | -49.1% | -54.8% |
Return on assets (ROA) | -1.8% | -0.6% | -0.2% |
Current ratio | 41.2% | 9.3% | 17.4% |
Return on equity (ROE) | -984.7% | -365.5% | -180.0% |
Change turnover | 258 | 866 | 2,443 |
Change turnover % | 7% | 31% | 466% |
Chg. No. of employees | 0 | -3 | 3 |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.